Pooled analysis of tobacco use and risk of Parkinson disease
- PMID: 17620489
- DOI: 10.1001/archneur.64.7.990
Pooled analysis of tobacco use and risk of Parkinson disease
Abstract
Context: Epidemiologic studies have reported that cigarette smoking is inversely associated with Parkinson disease (PD). However, questions remain regarding the effect of age at smoking onset, time since quitting, and race/ethnicity that have not been addressed due to sample size constraints. This comprehensive assessment of the apparent reduced risk of PD associated with smoking may provide important leads for treatment and prevention.
Objective: To determine whether race/ethnicity, sex, education, age at diagnosis, and type of tobacco modify the observed effects of smoking on PD.
Design, setting, and participants: We conducted the first ever pooled analysis of PD combining individual-level data from 8 US case-control and 3 cohort studies (Nurses' Health Study, Health Professionals Follow-Up Study, and Honolulu-Asia Aging Study) conducted between 1960 and 2004. Case-control studies provided data for 2328 PD cases and 4113 controls matched by age, sex, and ethnicity; cohort studies contributed 488 cases and 4880 controls selected from age- and sex-matched risk sets.
Main outcome measure: Incident PD.
Results: We confirmed inverse associations between PD and smoking and found these to be generally stronger in current compared with former smokers; the associations were stronger in cohort than in case-control studies. We observed inverse trends with pack-years smoked at every age at onset except the very elderly (>75 years of age), and the reduction of risk lessened with years since quitting smoking. The risk reductions we observed for white and Asian patients were not seen in Hispanic and African American patients. We also found an inverse association both for smoking cigars and/or pipes and for chewing tobacco in male subjects.
Conclusions: Our data support a dose-dependent reduction of PD risk associated with cigarette smoking and potentially with other types of tobacco use. Importantly, effects seemed not to be influenced by sex or education. Differences observed by race and age at diagnosis warrant further study.
Similar articles
-
Smoking and Parkinson's disease: a dose-response relationship.Neurology. 1999 Jan 1;52(1):115-9. doi: 10.1212/wnl.52.1.115. Neurology. 1999. PMID: 9921857
-
Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease.Neurology. 2014 Oct 14;83(16):1396-402. doi: 10.1212/WNL.0000000000000879. Epub 2014 Sep 12. Neurology. 2014. PMID: 25217056 Free PMC article.
-
Family-based case-control study of cigarette smoking and Parkinson disease.Neurology. 2005 Feb 8;64(3):442-7. doi: 10.1212/01.WNL.0000150905.93241.B2. Neurology. 2005. PMID: 15699372
-
Race moderates the effect of menthol cigarette use on short-term smoking abstinence.Nicotine Tob Res. 2013 May;15(5):883-9. doi: 10.1093/ntr/nts335. Epub 2013 Jan 3. Nicotine Tob Res. 2013. PMID: 23288873 Free PMC article.
-
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Clin Ther. 2008. PMID: 18555928 Review.
Cited by
-
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.Clin Geriatr Med. 2020 Feb;36(1):1-12. doi: 10.1016/j.cger.2019.08.002. Epub 2019 Aug 24. Clin Geriatr Med. 2020. PMID: 31733690 Free PMC article. Review.
-
Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study.Neuroepidemiology. 2010;34(1):50-4. doi: 10.1159/000260070. Epub 2009 Nov 21. Neuroepidemiology. 2010. PMID: 19940513 Free PMC article.
-
Influence of Cigarette Aerosol in Alpha-Synuclein Oligomerization and Cell Viability in SH-SY5Y: Implications for Parkinson's Disease.ACS Chem Neurosci. 2024 Apr 3;15(7):1484-1500. doi: 10.1021/acschemneuro.3c00771. Epub 2024 Mar 14. ACS Chem Neurosci. 2024. PMID: 38483468 Free PMC article.
-
Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.Neuropsychol Rev. 2015 Dec;25(4):371-83. doi: 10.1007/s11065-015-9303-z. Epub 2015 Nov 9. Neuropsychol Rev. 2015. PMID: 26553323 Review.
-
The epidemiology of Parkinson's disease.Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8. Lancet. 2024. PMID: 38245248 Free PMC article. Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
